Drug Database
Back to search

Poland· PL-100454307

Leukeran

A chlorambucil product containing chlorambucilum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.

ATC L01AA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLeukeranATCL01AA02REGISTER NO.PL-100454307PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chlorambucilumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chlorambucil is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AA02 (chlorambucil), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search chlorambucil products by name

Chlorambucil · ATC L01AA02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Chlorambucilum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
L01AA02
ATC class
Chlorambucil
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991457884

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

160 interactions on record for chlorambucil.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chlorambucil against other medicinesHow interaction checks work

Chlorambucil · interactions on record

160 records

  • 32 severe
  • 100 moderate
  • 14 minor
  • 14 info

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chlorambucil in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorambucil products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Leukeran
  • Belgium · Leukeran
  • Bulgaria · Леукеран
  • Czechia · Leukeran
  • Germany · Leukeran
  • Denmark · Leukeran
  • Estonia · Leukeran
  • Spain · Clorambucilo Aspen
  • Finland · Leukeran
  • France · Chloraminophene
  • United Kingdom (Northern Ireland) · Chlorambucil Aspen
  • Hungary · Leukeran
  • Ireland · Leukeran
  • Iceland · Leukeran
  • Italy · Leukeran
  • Lithuania · Leukeran
  • Luxembourg · Leukeran
  • Latvia · Leukeran
  • Malta · Leukeran
  • Netherlands · Leukeran
  • Norway · Leukeran
  • Portugal · Leukeran
  • Romania · Leukeran
  • Sweden · Leukeran
  • Slovenia · Leukeran
  • Slovakia · Leukeran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0480f627-0896-4f62-9c88-aa55d7b515b7
GET /v1/drugs/0480f627-0896-4f62-9c88-aa55d7b515b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909991457884 ¦ Rp ¦ 140821\n25 tabl.",
  "substance": "Chlorambucilum 2 mg",
  "common_name": "Chlorambucilum",
  "pl_product_id": "100454307",
  "pozwolenie_nr": "221/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2026-06-29"
}
API referenceMCP serverPlans

See everything about chlorambucil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console